1. Giving birth after fertility-sparing treatment for primary leiomyosarcoma of the fallopian tube.
- Author
-
Wang GZ, Xu HY, Deng SS, Gao JL, and Cheng JX
- Subjects
- Humans, Female, Pregnancy, Young Adult, Salpingectomy, Adult, Docetaxel therapeutic use, Docetaxel administration & dosage, Leiomyosarcoma surgery, Leiomyosarcoma drug therapy, Fertility Preservation methods, Fallopian Tube Neoplasms drug therapy, Fallopian Tube Neoplasms surgery
- Abstract
Primary leiomyosarcoma of the fallopian tube (PLFT) is an extremely rare gynecological malignancy that has only been described in case reports. Fertility-sparing treatment for PLFT has not been reported previously. A 24-year-old nulligravida woman was diagnosed with stage IC1 PLFT in the right fallopian tube after experiencing right lower quadrant pain for 2 weeks. She underwent laparoscopic right salpingectomy to preserve fertility followed by adjuvant chemotherapy with gemcitabine/docetaxel. She subsequently became pregnant spontaneously, delivering a term baby 27 months after treatment. This appears to be the only report of the use of fertility-preserving treatment for PLFT. The success of the treatment provides valuable information on the preservation of fertility in young women with PLFT., (© 2024 Japan Society of Obstetrics and Gynecology.)
- Published
- 2024
- Full Text
- View/download PDF